(Q41834152)

12 October 2017

PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation (English)

1 reference

12 October 2017

1 reference

Raoul Tibes

1

1 reference

12 October 2017

Steven M Kornblau

2

1 reference

12 October 2017

Yihua Qiu

3

1 reference

12 October 2017

Spyro M Mousses

4

1 reference

12 October 2017

Christiane Robbins

5

1 reference

12 October 2017

Tracy Moses

6

1 reference

12 October 2017

John D Carpten

7

1 reference

12 October 2017

language of work or name

English

0 references

publication date

5 December 2007

1 reference

12 October 2017

4

1 reference

British Journal of Haematology

inferred from page(s)

published in

1 reference

12 October 2017

140

1 reference

12 October 2017

3

1 reference

12 October 2017

344-347

1 reference

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385948

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385948

Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385948

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385948

Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385948

Antileukemic activity of rapamycin in acute myeloid leukemia.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385948

Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385948

Survival of acute myeloid leukemia cells requires PI3 kinase activation

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385948

Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia

18 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06920.X

Variation is the spice of life

21 January 2018

1 reference

12 December 2020

Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome

1 reference

12 December 2020

Assessment of somatic mutations in phosphatidylinositol 3-kinase gene in human lymphoma and acute leukaemia

1 reference

12 December 2020

Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies

1 reference

12 December 2020

10.1111/J.1365-2141.2007.06920.X

Identifiers

DOI

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

18053070

1 reference